Stockreport

Lipella Pharmaceuticals to Present at PropThink Digital Investor Conference

Lipella Pharmaceuticals Inc.  (LIPO) 
PDF PITTSBURGH, Feb. 20, 2024 (GLOBE NEWSWIRE) -- Lipella Pharmaceuticals Inc., (Nasdaq: LIPO) ("Lipella," "our," "us" or the "Company"), a pioneering, clinical-stage phar [Read more]